Furthermore, inorganic iron oxide NPs carrying therapeutic siRNAs were efficiently used for tracking siRNA-based gene therapy targeting the BCL2 and BIRC5 of oral cancer and glioblastoma cells [78]. The gene discussed is BCL2; the disease is glioblastoma.